Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders.
Risk of Multiple Sclerosis Among Persons with Epstein Barr Virus-Positive Mononucleosis: A Population-Based Study.
Naltrexone as an Antipruritic Agent for Surgical Scar Pruritus.
Possible role of hyperimmunoglobulin in reducing the risk of maternal-fetal transmission of cytomegalovirus in the valacyclovir era: a case series.
CAR T-Cell Therapy in Neurology: A Scoping Review of Neuro-Oncology, Autoimmune Diseases & Neurotoxicity.
Functional food literacy competencies of people with Parkinson's disease and multiple sclerosis: a qualitative study.
Correction: EEG biomarkers of microstructural damage in normal-appearing white matter among patients with neuromyelitis optica spectrum disorder: a DTI-EEG combined study.
Complexities in evaluation and management of infectious myelopathies.
Advances in nanotechnology for the diagnosis and management of autoimmune diseases.
No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients with progressive multifocal leukoencephalopathy.
The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells.
Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis.
Real-World Effectiveness and Safety of Ofatumumab: Analysis of B Cell Depletion, Comorbidities and Ethnicity in a Spanish Cohort.
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.
On the optimal sodium correction rate in hyponatraemia and clinical outcome: a meta-analysis.
Guillain-Barre syndrome should not be considered to be caused by an acute Zika infections unless PCR test for viral RNA is positive.
Mitigating Oxygen Electrostatic Repulsion in P'2 Mn-Based Layered Oxide Cathodes via K/Zn Dual Pillaring for Highly Stable Sodium-Ion Batteries.
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS.
Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry.
Comorbidities and Outcomes in People With Functional Neurological Disorder.
Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparison With Rituximab.
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.
Environmental enrichment modulates chronic poststroke inflammation and links white matter TREM2-positive microglia in recovery in mice.
Comparison of Pediatric Demyelinating Diseases using Axonal and Myelin-Sensitive MRI.
BCL6 promotes CCR2-driven CNS infiltration of encephalitogenic Th17 cells.
Pages
« first
‹ previous
…
838
839
840
841
842
843
844
845
846
…
next ›
last »